Reliability of Systematic and Targeted Biopsies versus Prostatectomy
Systematic Biopsy (SBx) has been and continues to be the standard staple for detecting prostate cancer. The more expensive MRI guided biopsy (MRITBx) is a better way of detecting cancer. The prostatectomy can provide an accurate condition of the prostate. The goal is to assess how reliable SBx and M...
Main Authors: | Tianyuan Guan, Abhinav Sidana, Marepalli B. Rao |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/10/12/1395 |
Similar Items
-
Impact of Surgeon’s Experience in Rigid versus Elastic MRI/TRUS-Fusion Biopsy to Detect Significant Prostate Cancer Using Targeted and Systematic Cores
by: Magdalena Görtz, et al.
Published: (2022-02-01) -
Comparison of Targeted Biopsy and Combined Biopsy to Avoid Unnecessary Systematic Biopsy in Patients with PI-RADS 5 Lesions
by: Changwei Yuan, et al.
Published: (2023-11-01) -
The Added Value of MRI-Based Targeted Biopsy in Biopsy-Naïve Patients: A Propensity-Score Matched Comparison
by: Gernot Ortner, et al.
Published: (2024-02-01) -
A novel biopsy scheme for prostate cancer: targeted and regional systematic biopsy
by: Yang He, et al.
Published: (2024-04-01) -
Does the type of biopsy used for diagnosis impact subsequent treatment selection in prostate cancer patients?
by: Brandon A. Levin, et al.
Published: (2022-12-01)